Early chemo switch not beneficial in patients with high circulating tumor cells
06 Aug 2024
byChristina Lau
In patients with metastatic breast cancer who failed to clear circulating tumor cells (CTCs) after one cycle of first-line chemotherapy, switching to a different chemotherapy does not improve survival or delay progression, the phase III SWOG S0500 trial has shown.